
LINKINGHUB . ELSEVIER . COM {
}
Title:
Synthetic therapeutic peptides: science and market - ScienceDirect
Description:
The decreasing number of approved drugs produced by the pharmaceutical industry, which has been accompanied by increasing expenses for R&D, demands alโฆ
Website Age:
32 years and 0 months (reg. 1993-07-02).
Matching Content Categories {๐}
- Science
- Education
- Careers
Content Management System {๐}
What CMS is linkinghub.elsevier.com built with?
Custom-built
No common CMS systems were detected on Linkinghub.elsevier.com, and no known web development framework was identified.
Traffic Estimate {๐}
What is the average monthly size of linkinghub.elsevier.com audience?
๐ Strong Traffic: 100k - 200k visitors per month
Based on our best estimate, this website will receive around 100,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Linkinghub.elsevier.com Make Money? {๐ธ}
We don't see any clear sign of profit-making.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Linkinghub.elsevier.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.
Keywords {๐}
peptides, drug, therapeutic, peptide, proteins, discov, development, synthetic, pharmaceutical, rev, volume, drugs, antibodies, toxicity, discovery, today, market, amps, toxic, access, increasing, candidates, strategies, chemical, nat, predicting, article, review, show, costs, terms, biological, properties, solubility, articles, biotechnol, lipinski, model, abstract, references, rights, content, number, industry, approaches, peptidebased, regulatory, study, cellular, stability,
Topics {โ๏ธ}
site-specific drug-delivery systems developing peptide/protein-based therapies prevent post-surgical adhesions peptide/protein-based drug discovery cell-free expression systems peptide-vector-mediated strategy peptide/protein-based therapy peptide-based drug discovery open access content h-bond formation rossi research advances host defense systems peptide-based drugs peptide-based drugs 2013 transporter-mediated permeation bloodโbrain barrier show abstract lower healthcare costs peptide drug candidates excretion processes play promote wound healing machine learning technique recommended articles identification newly identified defensin generic peptide products reduced drug pricing cell-penetrating peptides reducing attrition nat developing prediction models good drug candidates drug candidates compared synthetic therapeutic peptides natural amino acids recombinant dna technology revolution drug discov dipeptide-based model marketed peptide products peptide therapeutics curr host defense peptides lipidated incretin peptides development settings adv promising therapeutic molecules increasing economic pressure innovative formulation strategies pangalos drug development sato therapeutic peptides prolonged blood circulation drug development costs demands alternative approaches antosova therapeutic application
Questions {โ}
- Can the pharmaceutical industry reduce attrition rates?
- Cutting the cost of drug development?
- Is declining innovation in the pharmaceutical industry a myth?
- The cost of biopharmaceutical R&D: is biotech different?
- The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?
- Therapeutic application of peptides and proteins: parenteral for ever?
External Links {๐}(17)
- How much does https://www.elsevier.com/open-science/science-and-society/access-for-healthcare-and-patients earn?
- Get to know what's the income of https://doi.org/10.1016/j.drudis.2009.10.009
- How much does https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&contentID=S1359644609003705&orderBeanReset=true rake in every month?
- Profit of https://doi.org/10.3389/fcimb.2016.00194
- How much income is https://doi.org/10.1371/journal.pone.0073957 earning monthly?
- What is the earnings of https://doi.org/10.1038/s41392-022-00904-4?
- How much profit does https://doi.org/10.1111/cbdd.12055 make?
- Learn about the earnings of https://doi.org/10.1152/physrev.00049.2010
- Explore the financials of https://doi.org/10.1038/nature10702
- What's the profit of http://www.scopus.com/scopus/inward/citedby.url?partnerID=10&rel=3.0.0&eid=2-s2.0-74149094591&md5=24f548a73cda2caafda0a3ae70a1fe6e?
- How much profit is https://www.elsevier.com/ making per month?
- How much profit does https://www.elsevier.com/solutions/sciencedirect make?
- Get to know https://www.elsmediakits.com's earnings
- Income figures for https://service.elsevier.com/app/contact/supporthub/sciencedirect/
- https://www.elsevier.com/legal/elsevier-website-terms-and-conditions income
- What's the financial outcome of https://www.elsevier.com/legal/privacy-policy?
- https://www.relx.com/'s total income per month
CDN Services {๐ฆ}
- Cloudflare
- Com","assetRoute":"https://sdfestaticassets-us-east-1
- Com/content/image/","xocsMediaPlayerBaseUrl":"https://sdfestaticassets-us-east-1
- Com/content/image/1-s2
- Com/content/image/S13596446
- Cookielaw
- Pendo